INTERNATIONAL VACCINE RESEARCH CONGRESS

23–24 September 2025, Ankara
Online and In-Person Participation

CONGRESS SCHEDULE

Abstract submission deadline: 17 September 2025
Congress program publication date: 20 September 2025
Full paper submission deadline: 1 October 2025, 17:00 (strict deadline)
Publication date of the ISBN-registered proceedings book: 15 October 2025

CALL FOR PAPERS

The rapid developments in vaccine science and technology in recent years have profoundly impacted global healthcare systems and are shaping the future of public health. In this context, we are honored to organize the International Vaccine Research Congress, aiming to bring together scientists, healthcare professionals, industry representatives, and policymakers from around the world to share knowledge and experience.

Our congress will open discussions on a wide range of topics including innovative vaccine technologies, production processes, distribution and access strategies, vaccine safety, immunology, clinical research, and global health policies. Special sessions are planned for frontier areas such as the future of vaccine R&D in the post-pandemic period, AI-supported vaccine design, and vaccines for cancer and rare diseases.

CONGRESS COMMITTEE

Prof. Dr. Yasemin ÜSTÜNDAĞ, Fırat Üniversitesi

Doç. Dr. Demet ÇELEBİ, Atatürk Üniversitesi

Doç. Dr. Ethem İlhan ŞAHİN, Adana Alparslan Türkeş Bilim ve Teknoloji Üniversitesi

Prof. Dr. Froilan D. MOBO, PMM Akademisi, Filipinler

Dr. Mónika FEKETE, Semmelweis University, Hırvatistan

Moruf Adebayo ABIDOGUN, Lagos Devlet Üniversitesi

SCIENTIFIC COMMITTE

Prof. Dr. Yasemin ÜSTÜNDAĞ, Fırat Üniversitesi

Prof. Dr. Nodar SULASHVILI, Alte University, Gürcistan

Prof. Dr. Froilan D. MOBO, PMM Akademisi, Filipinler

Prof. Dr. Luiza GABUNIA, Tiflis Devlet Tıp Üniversitesi

Assoc. Prof. Dr. Jenifer Alat STEPHEN, Taşken Tıp Akademisi

Assoc. Prof. Dr. Ahmet YILMAZ, Atatürk Üniversitesi

Assoc. Prof. Dr. Demet ÇELEBİ, Atatürk Üniversitesi

Assoc. Prof. Dr. Ethem İlhan ŞAHİN, Adana Alparslan Türkeş Bilim ve Teknoloji Üniversitesi

Dr. Mónika FEKETE, Semmelweis University, Hırvatistan

Dr. Asma AWAN, University of Nevada, USA

Mayuree PAL, Presidency University, Hindistan

Moruf Adebayo ABIDOGUN, Lagos Devlet Üniversitesi

Hendri Hermawan ADİNUGRAHA, State Islamic University of K.H. Abdurrahman Wahid Pekalongan, Endonezya

Researchers wishing to join the congress committees must submit their CVs to the congress email address by 1 September 2025

DISCIPLINES AND TOPICS

The congress is open to vaccine-themed studies from all scientific disciplines, without topic limitations.
In addition, studies are particularly encouraged in the following areas:

1. Fundamental and Innovative Vaccine Technologies

Modern biotechnological approaches, next-generation platforms, and adjuvant technologies in vaccine development.
Subtopics:

Advances in mRNA and DNA Vaccines: Efficacy, safety, and clinical applications of nucleic acid-based vaccines.
The Future of Viral Vector and Protein Subunit Vaccines: Classical and innovative viral vector strategies and protein engineering.
Adjuvant Technologies and Immune Response Modulation: Development of next-generation adjuvants and their effects on immune response.
Nanotechnology and Cellular Platforms: Nanoparticle-based vaccines and cell-based production systems.

2. Clinical Research and Applications

Clinical trial processes, safety and efficacy evaluations, and strategies for diverse populations.
Subtopics:

New Approaches in Vaccine Clinical Trials: Phase I–IV processes, ethics, and accelerated approval procedures.
Vaccine Safety and Pharmacovigilance: Adverse event monitoring, risk management, and transparent reporting.
Vaccination in Special Populations: Pediatric, geriatric, and immunocompromised populations.
Post-Pandemic Vaccine Experiences: Lessons learned from COVID‑19 and other outbreaks.

3. Specialized Vaccines

Focused on strategic areas of public health and high-priority pathogens.
Subtopics:

Cancer and Immunotherapeutic Vaccines: Tumor antigen-targeted vaccines and personalized therapeutic approaches.
HIV, Ebola, and Challenging Pathogens: Novel vaccine designs for difficult-to-target diseases.
Veterinary Vaccines and the One Health Approach: Human-animal-environment interaction in vaccination.
Vaccines for Rare and Orphan Diseases: Strategies for neglected and low-prevalence conditions.

4. Data Science and Artificial Intelligence

Digitalization, AI, and big data in vaccine research and development.
Subtopics:

AI and Machine Learning in Vaccine Design: Antigen design, immune response modeling, and algorithmic approaches.
Big Data and Bioinformatics: Integration of genomic and proteomic data.
Digital Health and Monitoring Systems: Mobile health apps, digital vaccine passports, and data security.

5. Manufacturing, Distribution, and Access

Innovations and challenges in vaccine production, logistics, and accessibility.
Subtopics:

Sustainable Manufacturing Technologies: Next-generation production facilities and environmentally friendly methods.
Cold Chain and Logistics Management: Optimization of global supply chains.
Vaccine Access and Equity: Policies for low- and middle-income countries.
Intellectual Property and Patent Regulations: Impact on vaccine research and development.

6. Policies, Society, and Social Dimensions

Social acceptance, policymaking, and diplomatic approaches to vaccination.
Subtopics:

Tackling Vaccine Hesitancy and Anti-Vaccination Movements: Public health and social science perspectives.
Global Vaccine Policies and Diplomacy: Cooperation with WHO and other international organizations.
Economic and Social Impacts of Immunization Programs: Macroeconomic and cost-effectiveness analyses.
Community Engagement and Health Literacy: Education, media strategies, and public participation.

7. Pandemic Preparedness and Future Perspectives

Preparedness for new infectious threats and forward-looking research priorities.
Subtopics:

Post-COVID-19 Vaccine Strategies: Lessons learned and preparedness plans.
Emerging and Re-Emerging Infectious Diseases: Migration, climate change, and infection risks.
The Future Vaccine Ecosystem: Integrated global vaccine research networks.

SERVICES INCLUDED IN THE FEE

Publication of abstracts and full papers in an ISBN-registered proceedings book
Separate participation certificate (PDF) for all authors
Hot and cold refreshments during in-person sessions

Services Not Included: Accommodation and transportation.

CONGRESS LANGUAGES

English, Turkish

ABSTRACT & FULL PAPER SUBMISSION

Abstracts (200–300 words) must include an English abstract and be sent in Word format to akademikkongre@gmail.com by 17 September 2025.
Full paper submission is not mandatory. If you wish your full paper to be included in the proceedings book, submit it by 1 October 2025, 17:00 to akademikkongre@gmail.com
Similarity report (≤25%) must accompany full paper submissions.

FULL PAPER WRITING RULES

Times New Roman, 12 pt font
Line spacing 1.00, no indentation at paragraph beginnings
Section titles in UPPERCASE and bold
Any citation style acceptable
Minimum length: 4 pages
Sections: Abstract, Introduction, Research & Findings, Conclusion, References

REGISTRATION STEPS

Submit your abstract to akademikkongre@gmail.com by 17 September 2025.
Upon acceptance, pay the participation fee between 5–15 September 2025 and send the receipt along with presentation language (Turkish/English) and participation type (in-person/online).
If submitting a full paper, send it by 1 October 2025, 17:00 with similarity report (≤25%).
All remaining registration tasks will be completed by the coordinator.

CONTACT

Email: akademikkongre@gmail.com
WhatsApp: (messages only)

ORGANIZING COMMITTEE

Prof. Dr. Yasemin ÜSTÜNDAĞ, Fırat University

Assoc. Prof. Dr. Demet ÇELEBİ, Atatürk University

Assoc. Prof. Dr. Ethem İlhan ŞAHİN, Adana Alparslan Türkeş Science and Technology University

Prof. Dr. Froilan D. MOBO, PMMA

Dr. Mónika FEKETE, Semmelweis University

Moruf Adebayo ABIDOGUN, Lagos State University

SCIENCE COMMITTEE